BASILEA PHARMACEUTICA

Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Jan 2021)

What this means for you

This application is over — abandoned 04 Jan 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
87222044
Mark type
Stylized text
Filed
01 Nov 2016
Published for opposition
03 Oct 2017
Abandoned
04 Jan 2021
Attorney of record
Evan A. Raynes

Goods and services

  • Class 001 — Chemicals: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
  • Class 005 — Pharmaceuticals: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use (Class 001); Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents
  • Class 042 — Scientific and technological services: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Owner

Prosecution history

  • 04 Jan 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 04 Jan 2021 — ABANDONMENT - NO USE STATEMENT FILED
  • 13 May 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 12 May 2020 — SOU EXTENSION 5 GRANTED
  • 30 Apr 2020 — SOU EXTENSION 5 FILED
  • 30 Apr 2020 — SOU TEAS EXTENSION RECEIVED
  • 26 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 24 Oct 2019 — SOU EXTENSION 4 GRANTED
  • 24 Oct 2019 — SOU EXTENSION 4 FILED
  • 24 Oct 2019 — SOU TEAS EXTENSION RECEIVED
  • 29 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 27 May 2019 — SOU EXTENSION 3 GRANTED
  • 27 May 2019 — SOU EXTENSION 3 FILED
  • 27 May 2019 — SOU TEAS EXTENSION RECEIVED
  • 22 May 2019 — CORRECTED NOA E-MAILED

View this trademark record on Marksy